Gilde is deploying its Philips-backed healthcare fund, which the corporate venturing unit backed in 2010. Philips' Janke Dittmer [pictured] joined Gilde as a partner last year.

The biopharma company has taken its overall funding past the $60m mark, with participation from pharmaceutical corporations Pfizer, Novo and GlaxoSmithKline.

The Gen-Probe-backed food safety testing company's latest fundraising takes its total raised since it was founded two and a half years ago to $104.7m.

News provider CB Insights said, apart from Kaiser Permanente Ventures, the other investors in the round were venture capital firms

Cowen Royalty will target investments between $20m and $100 in US, Europe and Asian passive royalties, synthetic royalties and structured financings.

S&N will retain 49% of a company that in 2010 effectively made a trading profit of $44m on sales of $233m.

Neuroscience specialist H. Lundbeck has invested in Ossianix, developer of a treatment platform for problems linked to the central nervous system.